Plus, news about Spyre Therapeutics, Candel Therapeutics, Boehringer Ingelheim, Quantro Therapeutics, Clover, EVerZom and Apollomics:
🏛️ FDA pushes back decision on Denali Therapeutics’ Hunter syndrome treatment: The company is seeking accelerated approval of tividenofusp alfa ...
↧